F. Tulunay Et Al. , "The efficacy and safety of dipyrone (Novalgin (R)) tablets in the treatment of acute migraine attacks: a double-blind, cross-over, randomized, placebo-controlled, multi-center study," FUNCTIONAL NEUROLOGY , vol.19, no.3, pp.197-202, 2004
Tulunay, F. Et Al. 2004. The efficacy and safety of dipyrone (Novalgin (R)) tablets in the treatment of acute migraine attacks: a double-blind, cross-over, randomized, placebo-controlled, multi-center study. FUNCTIONAL NEUROLOGY , vol.19, no.3 , 197-202.
Tulunay, F., Ergun, H., Gulmez, S., Ozbenli, T., Ozmenoglu, M., Boz, C., ... Erdemoglu, A.(2004). The efficacy and safety of dipyrone (Novalgin (R)) tablets in the treatment of acute migraine attacks: a double-blind, cross-over, randomized, placebo-controlled, multi-center study. FUNCTIONAL NEUROLOGY , vol.19, no.3, 197-202.
Tulunay, FC Et Al. "The efficacy and safety of dipyrone (Novalgin (R)) tablets in the treatment of acute migraine attacks: a double-blind, cross-over, randomized, placebo-controlled, multi-center study," FUNCTIONAL NEUROLOGY , vol.19, no.3, 197-202, 2004
Tulunay, FC Et Al. "The efficacy and safety of dipyrone (Novalgin (R)) tablets in the treatment of acute migraine attacks: a double-blind, cross-over, randomized, placebo-controlled, multi-center study." FUNCTIONAL NEUROLOGY , vol.19, no.3, pp.197-202, 2004
Tulunay, F. Et Al. (2004) . "The efficacy and safety of dipyrone (Novalgin (R)) tablets in the treatment of acute migraine attacks: a double-blind, cross-over, randomized, placebo-controlled, multi-center study." FUNCTIONAL NEUROLOGY , vol.19, no.3, pp.197-202.
@article{article, author={FC Tulunay Et Al. }, title={The efficacy and safety of dipyrone (Novalgin (R)) tablets in the treatment of acute migraine attacks: a double-blind, cross-over, randomized, placebo-controlled, multi-center study}, journal={FUNCTIONAL NEUROLOGY}, year=2004, pages={197-202} }